Dysfunctionality of T cells in human tumor is characterized by the increased cell surface expression of inhibitory receptors, including PDCD1, LAG3, CTLA4, TIGIT and HAVCR2, and a reduced capacity of the cells to carry out classical CD8+ T cell effector functions [7, 8]. This evidence concerns the gene CD8A and neoplasm.